India, Nov. 28 -- image credit- shutterstock

India's private vaccine market grew 12% to Rs 2,217 crore in MAT October 2025, driven by strong performances from both established players and fast-rising challengers, according toSheetal Sapale, Vice President - Commercial at Pharmarack Technologies.

Dr. Reddy's Laboratories led the market with Rs 409 crore and an 18% share, followed by GSK at 16% and Serum Institute at 11%, all posting positive growth except GSK, which continues to show long-term decline with a -9% five-year CAGR. While Biological E and Abbott recorded stable gains, several prominent companies including Mankind, MSD, Panacea and Sun Pharma saw negative growth.

Elaborating more on growth of the private Indian vaccine market...